Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 31 Records) |
| Query Trace: Lung Neoplasms and EGF[original query] |
|---|
| The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib. European journal of pharmacology 2007 Sep 570 (1-3): 175-81. Nie Qiang, Wang Zhen, Zhang Guo-Chun, An She-Juan, Lin Jia-Yin, Guo Ai-Lin, Li Rong, Gan Bin, Huang Ying, Mok Tony S, Wu Yi-Lo |
| +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology (Carlton, Vic.) 2007 Nov 12 (6): 902-5. Kang Hyo-Gyoung, Choi Jin Eun, Lee Won Kee, Kam Sin, Cha Sung Ick, Kim Chang Ho, Jung Tae Hoon, Park Jae Yo |
| Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 2008 Oct 29 (10): 1938-43. Hosgood H Dean, Menashe Idan, Shen Min, Yeager Meredith, Yuenger Jeff, Rajaraman Preetha, He Xingzhou, Chatterjee Nilanjan, Caporaso Neil E, Zhu Yong, Chanock Stephen J, Zheng Tongzhang, Lan Qi |
| SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance. The pharmacogenomics journal 2010 Dec 10 (6): 513-23. Edvardsen H, Brunsvig P F, Solvang H, Tsalenko A, Andersen A, Syvanen A-C, Yakhini Z, Børresen-Dale A-L, Olsen H, Aamdal S, Kristensen V |
| Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. Lung cancer (Amsterdam, Netherlands) 2011 Oct 74 (1): 139-44. Tomizawa Kenji, Suda Kenichi, Onozato Ryoichi, Kosaka Takayuki, Endoh Hideki, Sekido Yoshitaka, Shigematsu Hisayuki, Kuwano Hiroyuki, Yatabe Yasushi, Mitsudomi Tetsu |
| The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain. BMC medical genetics 2011 12 (1): 144. Metzger Brigitte, Chambeau Laetitia, Begon Dominique Y, Faber Carlo, Kayser Jacques, Berchem Guy, Pauly Marc, Boniver Jacques, Delvenne Philippe, Dicato Mario, Wenner Thom |
| Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. Proceedings of the National Academy of Sciences of the United States of America 2012 Jul 109 (31): E2127-33. Ohashi Kadoaki, Sequist Lecia V, Arcila Maria E, Moran Teresa, Chmielecki Juliann, Lin Ya-Lun, Pan Yumei, Wang Lu, de Stanchina Elisa, Shien Kazuhiko, Aoe Keisuke, Toyooka Shinichi, Kiura Katsuyuki, Fernandez-Cuesta Lynnette, Fidias Panos, Yang James Chih-Hsin, Miller Vincent A, Riely Gregory J, Kris Mark G, Engelman Jeffrey A, Vnencak-Jones Cindy L, Dias-Santagata Dora, Ladanyi Marc, Pao Willi |
| EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Jun 21 (6): 988-92. Taga Masataka, Mechanic Leah E, Hagiwara Nobutoshi, Vähäkangas Kirsi H, Bennett William P, Alavanja Michael C R, Welsh Judith A, Khan Mohammed A, Lee Adam, Diasio Robert, Edell Eric, Bungum Aaron, Jang Jin Sung, Yang Ping, Jen Jin, Harris Curtis |
| Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Mar . de Mello RA, Ferreira M, Costa S, Costa BM, Pires FS, Neves I, Almeida MI, Cunha J, Oliveira P, Hespanhol V, Reis RM |
| High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Molecular cancer therapeutics 2012 May 11 (5): 1203-13. Levallet Guénaëlle, Bergot Emmanuel, Antoine Martine, Creveuil Christian, Santos Adriana O, Beau-Faller Michelle, de Fraipont Florence, Brambilla Elisabeth, Levallet Jérôme, Morin Franck, Westeel Virginie, Wislez Marie, Quoix Elisabeth, Debieuvre Didier, Dubois Fatéméh, Rouquette Isabelle, Pujol Jean-Louis, Moro-Sibilot Denis, Camonis Jacques, Zalcman Gérard, |
Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Carcinogenesis 2013 Feb 34 (2): 307-13. Lee Youngjoo, Yoon Kyong-Ah, Joo Jungnam, Lee Donghoon, Bae Kieun, Han Ji-Youn, Lee Jin S |
| Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations. Molecular cancer therapeutics 2013 Oct 12 (10): 2167-75. Wheler Jennifer J, Tsimberidou Apostolia M, Falchook Gerald S, Zinner Ralph G, Hong David S, Fok Jansina Y, Fu Siqing, Piha-Paul Sarina A, Naing Aung, Kurzrock Razel |
| A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Oct 19 (19): 5523-32. Johung Kimberly L, Yao Xiaopan, Li Fangyong, Yu James B, Gettinger Scott N, Goldberg Sarah, Decker Roy H, Hess Judith A, Chiang Veronica L, Contessa Joseph |
| DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan . Yeh P, Chen H, Andrews J, Naser R, Pao W, Horn L |
| Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study. Scientific reports 2014 4 4893. Li Chong, Wei Rongrong, Jones-Hall Yava L, Vittal Ragini, Zhang Min, Liu Wanqi |
| The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Apr 20 (7): 2001-10. Costa Carlota, Molina Miguel Angel, Drozdowskyj Ana, Giménez-Capitán Ana, Bertran-Alamillo Jordi, Karachaliou Niki, Gervais Radj, Massuti Bartomeu, Wei Jia, Moran Teresa, Majem Margarita, Felip Enriqueta, Carcereny Enric, Garcia-Campelo Rosario, Viteri Santiago, Taron Miquel, Ono Mayumi, Giannikopoulos Petros, Bivona Trever, Rosell Rafa |
| Expression of tumor necrosis factor-alpha-mediated genes predicts recurrence-free survival in lung cancer. PloS one 2014 12 9 (12): e115945. Wang Baohua, Song Ning, Yu Tong, Zhou Lianya, Zhang Helin, Duan Lin, He Wenshu, Zhu Yihua, Bai Yunfei, Zhu Mi |
| TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jul . Wei Rongrong, Cao Lan, Pu Hengying, Wang Hongwei, Zheng Yonglan, Niu Xiaomin, Weng Xiaoling, Zhang Hong, Favus Murray J, Zhang Lanjun, Jia Weihua, Zeng Yixin, Amos Christopher I, Lu Shun, Wang Hui-Yun, Liu Yun, Liu Wanqi |
| Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients. SpringerPlus 2015 4 171. Romero-Ventosa Elena Yaiza, Blanco-Prieto Sonia, González-Piñeiro Ana Lourdes, Rodríguez-Berrocal Francisco Javier, Piñeiro-Corrales Guadalupe, Páez de la Cadena Mar |
| Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Jun 10 (6): 910-23. Chen Nan, Fang Wenfeng, Zhan Jianhua, Hong Shaodong, Tang Yanna, Kang Shiyang, Zhang Yaxiong, He Xiaobo, Zhou Ting, Qin Tao, Huang Yan, Yi Xianping, Zhang |
| microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proceedings of the National Academy of Sciences of the United States of America 2015 Dec 112 (48): 14924-9. Gasparini Pierluigi, Cascione Luciano, Landi Lorenza, Carasi Stefania, Lovat Francesca, Tibaldi Carmelo, Alì Greta, D'Incecco Armida, Minuti Gabriele, Chella Antonio, Fontanini Gabriella, Fassan Matteo, Cappuzzo Federico, Croce Carlo |
| Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Translational oncology 2016 Aug 9 (4): 306-12. Sandfeld-Paulsen Birgitte, Folkersen Birgitte Holst, Rasmussen Torben Riis, Meldgaard Peter, Sorensen Boe |
| Association between genetic variants of EGF-containing fibulin-like extracellular matrix protein1 gene and sporadic breast cancer in a Chinese Han population. European journal of gynaecological oncology 2016 37 (1): 80-5. Li X, Quan Y, Tang C, Chen |
| Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Nov 11 (11): 1954-1961. Rosell Rafael, Neninger Elia, Nicolson Marianne, Huber Rudolf M, Thongprasert Sumitra, Parikh Purvish M, D'Hondt Er |
| EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Molecular biology reports 2019 Feb . Laus Ana Carolina, de Paula Flavia Escremim, de Lima Marcos Alves, Carlos Carolina Dias, Gomes Izabela Natalia Faria, de Marchi Pedro, Valente Jenna Kadja Neves, Pioltini Ana Beatriz Maringolo, Miziara José Elias, da Silva Carlos Maciel, Viana Luciano de Souza, Scapulatempo-Neto Cristovam, Reis Rui Manu |
| EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients. Thoracic cancer 2020 Sep . Leal Leticia F, Laus Ana C, Cavagna Rodrigo, de Paula Flavia E, de Oliveira Marco A, Ribeiro Dayana M, Hassan Fernanda M, Miziara José E, da Silva Eduardo C Albino, da Silva Vinicius D, De Marchi Pedro, Reis Rui |
| Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis. Medicine 2020 Apr 99 (17): e19456. Chen Quan, Zheng Yiming, Wu Bingbing, Chen Xia, Ge Pengfei, Wang Pengche |
| Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations. Future oncology (London, England) 2021 4 17 (22): 2867-2881. Winfree Katherine B, Molife Cliff, Peterson Patrick M, Chen Yongmei, Visseren-Grul Carla M, Leusch Mark S, Beyrer Julie, Dimou Anastasi |
| Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations. Cell proliferation 2024 7 e13708. Amanda Huee-Ping Wong, Min En Nga, Chin Yein Chin, Yee Kit Tai, Hung Chew Wong, Ross Soo, Omer An, Henry Yang, Ju Ee Seet, Yaw Chyn Lim, John Kit Chung Tam, Thai Tr |
| Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer. Cancer innovation 2024 7 3 (4): e110. Wei Chen, Haiyan Zhou, Mingyu Zhang, Yafei Shi, Taifeng Li, Di Qian, Jun Yang, Feng Yu, Guohui |
- Page last reviewed:Feb 1, 2024
- Content source: